Clinical Trial Update: A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing Pantovigar plus 2% Minoxidil versus 2% Minoxidil alone in women with female pattern hair loss/androgenetic alopecia has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss
• Ludwig Type
• Ludwig Type Ii

Drugs mentioned

• MINOXIDIL (Minoxidil)
• Pantovigar

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Female Pattern Hair Loss, Androgenetic Alopecia (AGA) | Phase 2 | Status: COMPLETED